Additionally, overexpression of AEG-1 and HIF-1α were significantly higher in patients with stage III or IV ovarian carcinoma, as opposed to stage I or II (p < 0.001 for both) [62]. This evidence concerns the gene MTDH and ovarian carcinoma.